Peptide Profiles

An identity-first review of Adamax explaining why sequence, molecular form and analytical confirmation must be established before biological evidence can be attributed.

A plain-English review of DSIP, from its original rabbit EEG research to very small older human studies and the evidence gaps that remain.

A plain-English review of KPV, its relationship to alpha-MSH, the laboratory and animal research, and why the current evidence does not establish a human outcome.

A plain-English review of AOD-9604, its relationship to one region of human growth hormone, the incomplete human research programme and the evidence gaps.

A plain-English review of cagrilintide, amylin signalling and current human research, including why CagriSema combination findings cannot be assigned to cagrilintide alone.

A plain-English review of SS-31 and elamipretide research, from cardiolipin and mitochondrial signalling to controlled human trials and the limits of evidence transfer.

A plain-English evidence review of Epitalon identity, cell-culture telomerase findings, animal lifespan research, sparse human studies and the unresolved longevity claims.

A plain-English evidence review of ipamorelin, ghrelin-receptor signalling, animal research, human hormone studies, the postoperative trial and remaining evidence gaps.

A plain-English evidence review of CJC-1295 with DAC, albumin binding, GH and IGF-1 biomarker studies, regulatory context and what remains unknown.